NCT06551272View on ClinicalTrials.gov

Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 12, 2025

Primary Completion Date

March 12, 2026

Study Completion Date

December 12, 2026

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

EXL01

EXL01 contains an unmodified single strain of F. prausnitzii

Trial Locations (6)

35000

RECRUITING

Centre de luttre contre le cancer Eugène Marquis, Rennes

92100

RECRUITING

Hôpital Beaujon, Clichy

93000

ACTIVE_NOT_RECRUITING

hôpital Avicenne, Bobigny

94805

ACTIVE_NOT_RECRUITING

Gustave ROUSSY, Villejuif

Unknown

ACTIVE_NOT_RECRUITING

CHU de Bordeaux, Bordeaux

44 000

ACTIVE_NOT_RECRUITING

CHU de Nantes Hotel Dieu, Nantes

All Listed Sponsors
lead

Center Eugene Marquis

OTHER